A Randomized, Double Blind, Placebo-controlled Study to Evaluate the Efficacy of Lavandula Angustifolia Containing Nasal Spray Medical Device in Preventing Deterioration of COVID-19 in Symptomatic Patients

The Grasses of Eden

Status: Unknown

Conditions: COVID-19 Infection

Treatments: Device: Nasal Spray Device

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT04974190

0037-21-COM1

Details and patient eligibility

About

A Nasal Spray device containing Dead Sea minerals and plant extracts, used to shorten duration and mitigate effects of Covid-19 infection in mild to moderate adult patients

Full description

A Nasal Spray device containing Dead Sea minerals and plant extracts, designed to incur a PPAR-alpha agonistic effect, used to shorten duration and mitigate effects of Covid-19 infection in mild to moderate adult patients

Enrollment: 550 estimated patients

Sex: All

Ages: 16 to 65 years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: Having tested positive to Covid-19 on PCR test -

Exclusion Criteria: Pregnancy Low blood pressure On immune system suppressing medications

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

550 participants in 2 patient groups, including a placebo group

Patients treated with actual device with actual solution

Active Comparator group

Treatment:

Device: Nasal Spray Device

Patients treated with actual device with placebo solution

Placebo Comparator group

Treatment:

Device: Nasal Spray Device